Correction: Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor? | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

See original article:

Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor? - March 01, 2021

Miscellaneous

Correction: Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?

Online download statistics by month:

Online download statistics by month: February 2023 to March 2024

	Abstract	Full	Pdf
Feb 2023	221	4	2
Mar 2023	483	3	2
Apr 2023	309	4	2
May 2023	58	2	1
Jun 2023	56	0	0
Jul 2023	33	0	1
Aug 2023	66	0	0
Sep 2023	12	0	0
Oct 2023	33	0	0
Nov 2023	43	1	0
Dec 2023	44	0	0
Jan 2024	21	0	0
Feb 2024	30	0	0
Mar 2024	22	0	0
Total	1431	14	8